MENU
REGN
AS OF
Nov 13, 04:59 PM (EDT)
Price
$695.46
Change
+$13.74 (+2.02%)
Capitalization
71.65B
78 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
REGN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Regeneron Pharmaceuticals (REGN) Ownership - Who owns Regeneron Pharmaceuticals?

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
777 Old Saw Mill River Road
Phone
+1 914 847-7000
Employees
13450
Web
https://www.regeneron.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
71.65B
P/E Ratio
16.34
Total Cash
7.47B
Projected Growth
1.35
Total Debt
2.71B
Revenue
14.21B
Risk (Beta)
0.59
Dividend Yield
0.00
Total Cash/Share
71.07
Total Debt/Equity
24.02
Revenue/Share
129.44 USD as % of share price

Fundamentals

REGN
Capitalization
71.6B
P/E Ratio
16.34
Risk (Beta)
0.59
Dividend Yield
0.00
Total Cash
7.47B
Total Cash/Share
71.07
Total Debt
2.71B
Total Debt/Equity
24.02
Projected Growth (PEG Ratio)
1.35
Revenue/Share (as % of the share price)
129.44%
Revenue
14.2B
ROE
N/A
Book Value
29.9B
P/B Ratio
2.31
Cash Flow
N/A
Earnings
41.73
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
100K
Current Ratio
4.60
Current Revenue Per Employee
241704.48
Dividends Per Share - Security
0.88
EBITDA
5.42B
Float
N/A
Float - Current
N/A
Gross Income Margin
85.58
Revenue To Assets
12.00
Shares Held By Institutions
157B
Shares Outstanding - Current
105M
Total Liabilities
8.28B
Total Volume MTD
N/A
Value
1
Gain YTD
-3.887
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
REGN
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. REGN showed earnings on October 28, 2025. You can read more about the earnings report here.
View AI-Driven Trading for REGN
A.I. Advisor
published General Information

General Information

a developer of medicines for the treatment of serious medical conditions

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
777 Old Saw Mill River Road
Phone
+1 914 847-7000
Employees
13450
Web
https://www.regeneron.com